Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasound, Peking University Cancer Hospital & Institute, No. 52 Fucheng Road, Haidian District, Beijing, China.
Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Radiology, Peking University Cancer Hospital & Institute, Beijing, China.
Eur Radiol. 2022 Mar;32(3):2060-2069. doi: 10.1007/s00330-021-08243-8. Epub 2021 Oct 30.
To explore the diagnostic value of contrast-enhanced ultrasound (CEUS) enhancement patterns for differentiating solid pancreatic lesions and compare them with conventional ultrasound (US) and enhanced computed tomography (CT).
A total of 210 patients with solid pancreatic lesions who had definite pathological or clinical diagnoses were enrolled. Six CEUS enhancement patterns were proposed for solid pancreatic lesions. Two US doctors blindly observed the CEUS patterns of solid pancreatic lesions and the interrater agreement was analyzed. The diagnostic value of CEUS enhancement patterns for differentiating solid pancreatic lesions was evaluated, and the diagnostic accuracy was compared with that of US and enhanced CT.
There was good concordance for six CEUS enhancement patterns of solid pancreatic lesions between the two doctors, with a kappa value of 0.767. Hypo-enhancement (Hypo-E) or centripetal enhancement (Centri-E) as the diagnostic criteria for pancreatic carcinoma had an accuracy of 87.62%; hyper-enhancement (Hyper-E) for neuroendocrine tumors had an accuracy of 92.89%; capsular enhancement with low or uneven enhancement inside the tumor (Capsular-E) for solid pseudopapillary tumors had an accuracy of 97.63%; and iso-enhancement (Iso-E) or iso-enhancement with focal hypo-enhancement (Iso-fhypo-E) for focal pancreatitis had an accuracy of 89.10%. The diagnostic accuracy of CEUS was significantly different from that of US for 210 cases of solid pancreatic lesions (p < 0.05) and was not significantly different from that of enhanced CT for 146 cases of solid pancreatic lesions (p > 0.05).
The different enhancement patterns of solid pancreatic lesions on CEUS were clinically valuable for differentiation.
• Six CEUS enhancement (E) patterns, including Hyper-E, Iso-E, Iso-fhypo-E, Hypo-E, Centri-E, and Capsular-E, are proposed for the characterization of solid pancreatic lesions. • Using Hypo-E or Centri-E as the diagnostic criteria for pancreatic carcinoma, Hyper-E for neuroendocrine tumors, Capsular-E for solid pseudopapillary tumors, and Iso-E or Iso-fhypo-E for focal pancreatitis on CEUS had relatively high diagnostic accuracy. • The diagnostic accuracy of CEUS was greatly increased over that of US and was not different from that of enhanced CT.
探讨超声造影(CEUS)增强模式对鉴别实性胰腺占位性病变的诊断价值,并与常规超声(US)和增强 CT 进行比较。
共纳入 210 例经明确病理或临床诊断为实性胰腺占位性病变的患者。提出了 6 种实性胰腺占位性病变的 CEUS 增强模式。由 2 位 US 医生盲法观察实性胰腺占位性病变的 CEUS 模式,并分析其组内一致性。评估 CEUS 增强模式对鉴别实性胰腺占位性病变的诊断价值,并与 US 和增强 CT 的诊断准确性进行比较。
2 位医生对 6 种实性胰腺占位性病变的 CEUS 增强模式具有较好的一致性,kappa 值为 0.767。以低增强(Hypo-E)或向心性增强(Centri-E)作为胰腺癌的诊断标准,其准确性为 87.62%;高增强(Hyper-E)用于神经内分泌肿瘤的准确性为 92.89%;实性假乳头状瘤的包膜增强伴瘤内低增强或不均匀增强(Capsular-E)的准确性为 97.63%;局灶性胰腺炎的等增强(Iso-E)或等增强伴局灶性低增强(Iso-fhypo-E)的准确性为 89.10%。CEUS 对 210 例实性胰腺占位性病变的诊断准确性与 US 比较,差异有统计学意义(p<0.05),与 146 例实性胰腺占位性病变的增强 CT 比较,差异无统计学意义(p>0.05)。
CEUS 上实性胰腺占位性病变的不同增强模式对鉴别诊断具有临床价值。